Viewing Study NCT02228304

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2026-03-29 @ 3:19 AM
Study NCT ID: NCT02228304
Status: TERMINATED
Last Update Posted: 2022-07-18
First Post: 2014-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Sponsor: Neurotech Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Wet AMD View
None Wet Age Related Macular Degeneration View
None Recurrent CNV Secondary to AMD View
None Active subfoveal CNV View